Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(4.17)
# 1,570
Out of 4,978 analysts
115
Total ratings
37.7%
Success rate
13.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Prakhar Agrawal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IVA Inventiva | Initiated Coverage: Buy | n/a | $3.86 | - | 1 | Jul 17, 2026 | |
| SLN Silence Therapeutics | Initiated Coverage: Buy | n/a | $12.46 | - | 1 | Jun 24, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $101 | $38.95 | +159.31% | 10 | Jun 7, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | n/a | $5.97 | - | 1 | Apr 27, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | n/a | $103.89 | - | 1 | Mar 1, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | n/a | $62.51 | - | 7 | Feb 20, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | n/a | $12.20 | - | 9 | Dec 4, 2025 | |
| EVMN Evommune | Initiated Coverage: Buy | n/a | $9.99 | - | 1 | Dec 1, 2025 | |
| MDGL Madrigal Pharmaceuticals | Upgraded: Buy | n/a | $523.26 | - | 4 | Nov 4, 2025 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | n/a | $5.53 | - | 2 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.36 | - | 6 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.3892 | n/a | 10 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $16.07 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.40 | n/a | 1 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $39.50 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.67 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.04 | n/a | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.17 | n/a | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $2.8 | $2.05 | n/a | 10 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.99 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3.5 | $1.41 | n/a | 3 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $5.82 | n/a | 8 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $62 | $8.16 | n/a | 8 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $23.51 | n/a | 8 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $1.37 | n/a | 8 | Aug 5, 2021 |
Inventiva
Jul 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $3.86
Upside: -
Silence Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $12.46
Upside: -
Structure Therapeutics
Jun 7, 2026
Reiterated: Buy
Price Target: $101
Current: $38.95
Upside: +159.31%
Shattuck Labs
Apr 27, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $5.97
Upside: -
Veradermics
Mar 1, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $103.89
Upside: -
Travere Therapeutics
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $62.51
Upside: -
MoonLake Immunotherapeutics
Dec 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $12.20
Upside: -
Evommune
Dec 1, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $9.99
Upside: -
Madrigal Pharmaceuticals
Nov 4, 2025
Upgraded: Buy
Price Target: n/a
Current: $523.26
Upside: -
Aclaris Therapeutics
Oct 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.53
Upside: -
Sep 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $12.36
Upside: -
Sep 15, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.3892
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $16.07
Upside: n/a
Jul 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.40
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $39.50
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $70.67
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: n/a
Current: $53.04
Upside: n/a
Jan 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $11.17
Upside: n/a
Aug 11, 2023
Reiterated: Buy
Price Target: $14 → $2.8
Current: $2.05
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $4.99
Upside: n/a
Jan 10, 2023
Reiterated: Buy
Price Target: $5 → $3.5
Current: $1.41
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: $27 → $23
Current: $5.82
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $58 → $62
Current: $8.16
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $44
Current: $23.51
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $22
Current: $1.37
Upside: n/a